Levine Mark S.
SEC CIK 1617236 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | CLO | 319.2K | — | $2.10M | 21 | 2022-01-28 | 2024-11-20 |
Most active insiders at IMVT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| 2 | Fromkin Andrew J. | Dir | — | $7.96M |
| 3 | Stout Jay S | CTO | — | $2.27M |
| 4 | Gloria Melanie | COO | — | $1.60M |
| 5 | Girao Tiago | CFO | — | $1.41M |
| 6 | Van Tuyl Christopher | CLO | — | $1.31M |
| 7 | Venker Eric | CEO, Dir | — | $461.8K |
| 8 | Pande Atul | Dir | — | $424.6K |
| 9 | Hughes Douglas J. | Dir | — | $348.7K |
| 10 | Geffner Michael | Chief Medical Off | — | $70.1K |
Levine Mark S. made no open-market trades at IMVT in the last 12 months.
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-22 | 2024-11-20 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $25.45 | -3,650 | 319.2K | -1% | -$92.9K | |
| 2024-10-25 | 2024-10-23 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $29.53 | -4,361 | 322.9K | -1% | -$128.8K | |
| 2024-10-18 | 2024-10-16 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $28.79 | -2,860 | 327.2K | -0.9% | -$82.3K | |
| M | 2024-08-23 | 2024-08-21 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $31.86 | -3,295 | 330.2K | -1.0% | -$105.0K |
| 2024-07-26 | 2024-07-24 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $27.76 | -4,015 | 333.4K | -1% | -$111.5K | |
| M | 2024-07-19 | 2024-07-17 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $29.69 | -2,505 | 337.4K | -0.7% | -$74.4K |
| 2024-05-24 | 2024-05-22 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $29.65 | -3,242 | 339.9K | -0.9% | -$96.1K | |
| 2024-04-26 | 2024-04-24 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $28.90 | -3,963 | 343.2K | -1% | -$114.5K | |
| M | 2024-04-19 | 2024-04-17 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $29.06 | -9,827 | 347.1K | -3% | -$285.6K |
| D | 2024-04-04 | 2024-04-02 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | A - Grant | $0.00 | +55.0K | 356.9K | +18% | $0 |
| 2024-02-23 | 2024-02-22 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $36.15 | -2,134 | 302.0K | -0.7% | -$77.1K | |
| M | 2024-01-29 | 2024-01-26 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $37.92 | -3,027 | 304.1K | -1.0% | -$114.8K |
| M | 2023-11-24 | 2023-11-22 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $32.78 | -3,252 | 307.1K | -1% | -$106.6K |
| 2023-10-27 | 2023-10-25 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $34.66 | -4,107 | 310.4K | -1% | -$142.3K | |
| M | 2023-08-25 | 2023-08-24 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $20.30 | -12.3K | 314.5K | -4% | -$249.4K |
| 2023-07-27 | 2023-07-26 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $21.63 | -3,917 | 326.8K | -1% | -$84.7K | |
| 2023-04-26 | 2023-04-25 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $16.29 | -2,633 | 330.7K | -0.8% | -$42.9K | |
| D | 2023-04-14 | 2023-04-12 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | A - Grant | $0.00 | +87.7K | 333.3K | +36% | $0 |
| 2023-01-27 | 2023-01-26 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | S - Sale | $18.51 | -10.2K | 245.7K | -4% | -$188.0K | |
| D | 2022-08-19 | 2022-08-17 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | A - Grant | $0.00 | +112.8K | 255.8K | +79% | $0 |
| D | 2022-01-31 | 2022-01-28 | IMVT | Immunovant, Inc. | Levine Mark S. | CLO | A - Grant | $0.00 | +143.0K | 143.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations